Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore W Randolph

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
Journal of Pharmaceutical Sciences|February 9, 2002
A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20Serena D Webb, Jeffrey L Cleland, John F Carpenter, et al.
Methods in Enzymology|October 19, 2006
High-pressure studies on protein aggregates and amyloid fibrilsYong-Sung Kim, Theodore W Randolph, Matthew B Seefeldt, et al.
Journal of Pharmaceutical Sciences|November 1, 2005
Population balance modeling of aggregation kinetics of recombinant human interleukin-1 receptor antagonistEva Y Chi, Brent S Kendrick, John F Carpenter, et al.
Protein Science : a Publication of the Protein Society|February 2, 2018
Protein-protein interactions controlling interfacial aggregation of rhIL-1ra are not described by simple colloid modelsLea L Sorret, Madison A DeWinter, Daniel K Schwartz, et al.
The Journal of Biological Chemistry|May 23, 2002
Kinetics and energetics of assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein. Insights into transition states from pressure, temperature, and co-solute studiesYong-Sung Kim, Theodore W Randolph, Fred J Stevens, et al.
Biochemistry|November 11, 2009
Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stabilityJonas L Fast, Amanda A Cordes, John F Carpenter, et al.
Journal of Pharmaceutical Sciences|November 7, 2009
Protein adsorption and excipient effects on kinetic stability of silicone oil emulsionsD Brett Ludwig, John F Carpenter, Jean-Bernard Hamel, et al.
Journal of Pharmaceutical Sciences|October 10, 2007
High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kineticsJohn R Alford, Brent S Kendrick, John F Carpenter, et al.
Journal of Pharmaceutical Sciences|January 3, 2013
IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containersPinaki Basu, Sampathkumar Krishnan, Renuka Thirumangalathu, et al.
Biophysical Journal|November 3, 2016
Challenges in Predicting Protein-Protein Interactions from Measurements of Molecular DiffusivityLea L Sorret, Madison A DeWinter, Daniel K Schwartz, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Journal of Pharmaceutical Sciences|February 9, 2002
A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20Serena D Webb, Jeffrey L Cleland, John F Carpenter, et al.
Methods in Enzymology|October 19, 2006
High-pressure studies on protein aggregates and amyloid fibrilsYong-Sung Kim, Theodore W Randolph, Matthew B Seefeldt, et al.
Journal of Pharmaceutical Sciences|November 1, 2005
Population balance modeling of aggregation kinetics of recombinant human interleukin-1 receptor antagonistEva Y Chi, Brent S Kendrick, John F Carpenter, et al.
Protein Science : a Publication of the Protein Society|February 2, 2018
Protein-protein interactions controlling interfacial aggregation of rhIL-1ra are not described by simple colloid modelsLea L Sorret, Madison A DeWinter, Daniel K Schwartz, et al.
The Journal of Biological Chemistry|May 23, 2002
Kinetics and energetics of assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein. Insights into transition states from pressure, temperature, and co-solute studiesYong-Sung Kim, Theodore W Randolph, Fred J Stevens, et al.
Biochemistry|November 11, 2009
Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stabilityJonas L Fast, Amanda A Cordes, John F Carpenter, et al.
Journal of Pharmaceutical Sciences|November 7, 2009
Protein adsorption and excipient effects on kinetic stability of silicone oil emulsionsD Brett Ludwig, John F Carpenter, Jean-Bernard Hamel, et al.
Journal of Pharmaceutical Sciences|October 10, 2007
High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kineticsJohn R Alford, Brent S Kendrick, John F Carpenter, et al.
Journal of Pharmaceutical Sciences|January 3, 2013
IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containersPinaki Basu, Sampathkumar Krishnan, Renuka Thirumangalathu, et al.
Biophysical Journal|November 3, 2016
Challenges in Predicting Protein-Protein Interactions from Measurements of Molecular DiffusivityLea L Sorret, Madison A DeWinter, Daniel K Schwartz, et al.
Pageof 18